Archives
Study: Imaging of Coronary Inflammation for Cardiovascular Risk Prediction
31 Aug, 2018 | 02:28h | UTCCommentaries: Imaging of coronary inflammation for cardiovascular risk prediction – The Lancet (free) AND New Imaging Biomarker of Coronary Inflammation Shows Prognostic Value Exceeding All Current Noninvasive Measures – Cleveland Clinic (free) AND Imaging biomarker can predict coronary inflammation – UPI (free)
Study: Deep Forehead Wrinkles May Signal a Higher Risk for Cardiovascular Mortality
31 Aug, 2018 | 02:10h | UTCDeep forehead wrinkles may signal a higher risk for cardiovascular mortality – ESC Press Releases (free)
Commentaries: Forehead wrinkles – an early sign of cardiovascular disease? – Medical News Today (free) AND Excessive forehead wrinkles may be early sign of atherosclerosis – Cardiovascular Business (free)
Cohort Study: Psychological Distress and Risk of Myocardial Infarction and Stroke
31 Aug, 2018 | 02:10h | UTCCommentaries: Distress boosts heart attack and stroke risk – Medical News Today (free) AND High Mental Distress Tied to Heart Troubles – MedPage Today (free registration required)
Report: Improving Health Care Worldwide
31 Aug, 2018 | 02:09h | UTCVideos: The Scope of the Problem (free) AND Health Systems of the Future (free)
See also: Report Highlights (free PDF) AND Recommendations (free PDF)
Randomized Trial: One-Year Outcomes after PCI Strategies in Cardiogenic Shock
31 Aug, 2018 | 02:05h | UTCOne-Year Outcomes after PCI Strategies in Cardiogenic Shock – New England Journal of Medicine (free for a limited period)
Commentaries: Less Is Still More in Patients with Acute Myocardial Infarction and Cardiogenic Shock – NEJM Journal Watch (free for a limited period) AND 1-year outcomes still support culprit-only PCI for cardiogenic shock – Cardiovascular Business (free) CULPRIT-SHOCK: 1-Year Results Continue to Support Culprit-Only PCI for Shock Patients – TCTMD (free)
Randomized Trial: Telemedicine in Heart Failure Patients
31 Aug, 2018 | 02:04h | UTCEfficacy of telemedical interventional management in patients with heart failure (TIM-HF2): a randomised, controlled, parallel-group, unmasked trial – The Lancet (link to abstract – $ for full-text)
Commentaries: Telemedicine in Heart Failure Patients (TIM-HF2) – American College of Cardiology (free) AND ESC: Telemonitoring of HF Cuts Admissions, Mortality MedPage Today (free registration required)
Global Mortality from Firearms, 1990-2016
31 Aug, 2018 | 02:03h | UTCGlobal Mortality From Firearms, 1990-2016 – JAMA (free for a limited period)
Video Summary: Global Firearm Mortality, 1990-2016 – JAMA (free)
Infographic: Firearm deaths around the world 1990–2016 – Institute for Health Metrics and Evaluation (free) (via @kleachkemon)
Commentaries: Six countries in the Americas account for half of all firearm deaths – Institute for Health Metrics and Evaluation (free) AND Gun-related homicides, suicides kill more people than war, study says – CNN (free)
Case-Control Studies: Using “Real-world” Evidence to Assess Association
31 Aug, 2018 | 02:01h | UTCGuide to Statistics and Methods: Case-Control Studies: Using “Real-world” Evidence to Assess Association – JAMA (free for a limited period)
Zackary Berger’s journal reviews, 28 August 2018
31 Aug, 2018 | 02:02h | UTCZackary Berger’s journal reviews, 28 August 2018 – The BMJ Opinion (free)
Randomized Trial: Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients
31 Aug, 2018 | 01:58h | UTCCardiovascular Safety of Lorcaserin in Overweight or Obese Patients – New England Journal of Medicine (free for a limited period)
Editorial: Lorcaserin — Elixir or Liability? (free for a limited period)
Commentaries: CAMELLIA-TIMI 61: Weight Loss Drug Lorcaserin Did Not Increase CV Events – American College of Cardiology (free) AND Weight-Loss Drug Lorcaserin Clears Cardiovascular Safety Hurdle: CAMELLIA-TIMI 61 – TCTMD (free) AND Weight loss drug lorcaserin found safe in large study – Reuters (free)
Guiding Principles for the Care of People with or at Risk for Diabetes
31 Aug, 2018 | 02:00h | UTCCommentaries: NIDDK Updates ‘Guiding Principles’ for Diabetes, Prediabetes – Medscape (free registration required) AND NDEP revises principles for managing diabetes, prediabetes – Cardiovascular Business (free)
Related Book: Diabetes in America, 3rd Edition – National Institutes of Health (free reference book, just released)
Randomized Trial: Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness
31 Aug, 2018 | 01:57h | UTCRivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness – New England Journal of Medicine (free for a limited period)
Commentaries: VTE risk unchanged by rivaroxaban after discharge – The Hospitalist (free) AND MARINER: Rivaroxaban vs. Placebo Post-Discharge in Patients at High Risk For VTE – American College of Cardiology (free) AND MARINER: No Reduction in Death, VTE With Rivaroxaban After Discharge in Medically Ill Patients – Medscape (free registration required)
Review: Acute Clinical Care for Transgender Patients
31 Aug, 2018 | 01:59h | UTCAcute Clinical Care for Transgender Patients – JAMA Internal Medicine (free for a limited period) (via @CarlosdelRio7)
Cohort Study: No Survival Benefit with Beta-Blockers Beyond 1 Year Post-MI in Stable CAD
31 Aug, 2018 | 01:55h | UTCCLARIFY: No Survival Benefit With Beta-Blockers Beyond 1 Year Post-MI in Stable CAD – TCTMD (free)
Related Study: B-Blockers and Mortality After Acute Myocardial Infarction in Patients Without Heart Failure or Ventricular Dysfunction (free study and commentary)
“The problem, said Sorbets, is that there have never been large randomized trials to test the prognostic effects of beta-blockers in this patient group and instead, recommendations have been drawn from meta-analyses using data extracted from the acute MI setting or from observational studies.”
Randomized Trial: Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy
31 Aug, 2018 | 01:56h | UTCTafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy – New England Journal of Medicine (free for a limited period)
Editorial: Stabilizing Transthyretin to Treat ATTR Cardiomyopathy (free for a limited period)
Commentaries: Tafamidis, a Transthyretin Stabilizer, Offers Hope for Rare Cardiomyopathy – TCTMD (free) AND ATTR-ACT: Tafamidis Findings Offer Hope For Patients With ATTR-CM – American College of Cardiology (free) AND Drug reduces deaths and hospitalizations from underdiagnosed form of heart failure – Columbia University Irving Medical Center, via EurekAlert (free)
Overview of Cochrane Reviews: Assisted Reproductive Technology
31 Aug, 2018 | 01:51h | UTCAssisted reproductive technology: an overview of Cochrane Reviews – Cochrane Library (free for a limited period)
Study: Coronary CT Angiography and 5-Year Risk of Myocardial Infarction
31 Aug, 2018 | 01:55h | UTCCoronary CT Angiography and 5-Year Risk of Myocardial Infarction – New England Journal of Medicine (free for a limited period)
Commentary: Five Reasons I Don’t Believe an Imaging Test Improves Outcomes – by Dr. John Mandrola, in Medscape (free registration required)
See also an interesting Tweetorial by @AnilMakam, also suggesting caution before adopting this study results in clinical practice.
Perspective: Using a New EHR System to Increase Patient Engagement, Improve Efficiency, and Decrease Cost
31 Aug, 2018 | 01:49h | UTC“Another solution might be to capitalize on patients’ vested interest in their own health care by actively engaging them in the entry of their own medical history information into the EHR.”
Perspective: The Community Health Worker Boom
31 Aug, 2018 | 01:50h | UTCThe Community Health Worker Boom – NEJM Catalyst (free)
“The key question is not whether community health workers are effective, but how we can make them as effective as possible.”
Review: Treatment of Invasive Candidiasis
31 Aug, 2018 | 01:47h | UTCTreatment of Invasive Candidiasis: A Narrative Review – Journal of Fungi (free)
Source: Hospital Medicine Virtual Journal Club
Cochrane Review: Xpert® MTB/RIF Test for Diagnosing Extrapulmonary TB
31 Aug, 2018 | 01:48h | UTCXpert® MTB/RIF assay for extrapulmonary tuberculosis and rifampicin resistance – Cochrane Library (free for a limited period)
Summary: Xpert® MTB/RIF test for diagnosing extrapulmonary tuberculosis and rifampicin resistance – Cochrane Library (free)
Commentary: Cochrane review looks at the accuracy of Xpert® MTB/RIF for the diagnosis of extrapulmonary TB – Liverpool School of Tropical Medicine (free)
Viewpoint: Navigating the Ethical Boundaries of Grateful Patient Fundraising
31 Aug, 2018 | 01:46h | UTCNavigating the Ethical Boundaries of Grateful Patient Fundraising – JAMA (free for a limited period)
Opinion: Publish Peer Reviews
31 Aug, 2018 | 01:47h | UTCPublish peer reviews – Nature News (free)
“Jessica K. Polka and colleagues call on journals to sign a pledge to make reviewers’ anonymous comments part of the official scientific record.”
Study: Emergency Department Visits for Adverse Drug Events from Antibiotics in Children
31 Aug, 2018 | 01:44h | UTCCommentaries: Antibiotic side effects send 70,000 children to ER each year, study says – UPI (free) AND Antibiotic side-effects in kids lead to nearly 70,000 ER visits in the US each year – Pediatric Infectious Diseases Society, via ScienceDaily (free)
PURE Study: Redefined ‘High-Quality’ Diet Lowers Risk of All-Cause Mortality
31 Aug, 2018 | 01:43h | UTCRedefined ‘High-Quality’ Diet Lowers Risk of All-Cause Mortality: PURE – TCTMD (free)